# Carmat TAH Early Feasibility Study

> **NCT04117295** · NA · SUSPENDED · sponsor: **Carmat SAS** · enrollment: 10 (estimated)

## Conditions studied

- End-stage Heart Failure

## Interventions

- **DEVICE:** Carmat Total Artificial Heart

## Key facts

- **NCT ID:** NCT04117295
- **Lead sponsor:** Carmat SAS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-07-12
- **Primary completion:** 2026-04
- **Final completion:** 2027-01
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Occurrence of a quality issue affecting some of its prostheses
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04117295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04117295, "Carmat TAH Early Feasibility Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04117295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*